A recent study reported CD74 gene fusions in patients with lung cancer harboring the kinase domain of the NTRK1 gene that encodes the TRKA receptor. CD74-NTRK1 fusions result in constitutive TRKA kinase development and are oncogenic. This evidence concerns the gene NTRK1 and lung carcinoma.